Lantus SOLOSTAR - Sanofi

Page 1 LANTUS ® SOLOSTAR ® Instruction Leaflet . SoloSTAR ® is a prefilled pen for the injection of insulin. Your health professional has decided that SoloSTAR is appropriate for you, based on your ability to handle SoloSTAR.

  Insulin, Lantus, Lantus solostar, Solostar, 174 solostar

PRODUCT MONOGRAPH - Sanofi

PLAVIX Product Monograph Page 1 of 55 . PRODUCT MONOGRAPH . PrPLAVIX®. Clopidogrel Tablets, Manufacturer’s Standard . 75 …

Kayexalate (sodium polystyrene sulfonate) - Sanofi

KAYEXALATE (sodium polystyrene sulfonate) is a cream or light brown fine powder of sodium polystyrene sulfonate. KAYEXALATE is a cation-exchange resin prepared in the

  Kayexalate

Thymoglobulin (anti-thymocyte globulin [rabbit]) - …

Live vaccines should not be administered to patients about to receive, receiving, or after treatment with Thymoglobulin. Concomitant administration of Thymoglobulin with live virus

  Administered, Be administered

PRODUCT MONOGRAPH - Sanofi

CLOLAR® (clofarabine for injection) Page 1 of 41. PRODUCT MONOGRAPH . PrCLOLAR®. Clofarabine for injection . 1 mg/mL (20 mg/20 mL) Antineoplastic Agent . sanofi-aventis Canada Inc. 2905 Place Louis-R.-Renaud

  Product, Monographs, Sanofi, Product monograph, Product monograph sanofi

Myochrysine (sodium aurothiolamate) - Sanofi

3 It is usually used for treating patients who show evidence of continued or additional disease activity despite conservative drug therapy, e.g. with salicylates or …

  Myochrysine

PRODUCT MONOGRAPH INCLUDING PATIENT …

ADLYXINE - Product Monograph Page 1 of 79. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ADLYXINE™ . lixisenatide injection . 0.05 mg per mL (10 μg/dose)

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information

PRODUCT MONOGRAPH INCLUDING PATIENT …

Page 1 of 64. PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION . PrPRALUENT®. alirocumab . solution for subcutaneous injection . 75 mg/mL and 150 mg/mL

  Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Including patient medication information

Renvela (sevelamer carbonate) - Sanofi

Renvela (sevelamer carbonate) Product Monograph Page 1 of 21. PRODUCT MONOGRAPH . PrRENVELA®. sevelamer carbonate tablets . 800 mg . Phosphate Binder . ATC code: VO3A EO2

  Sanofi, Renvela

Sculptra (poly-L-lactic acid) - Sanofi

Application number: 200845 Page 1 of 7 Date of revision: September 17, 2012 s-a Version 2.3 dated September 19, 2012 Instruction Leaflet SCULPTRA® poly-L-lactic acid

  Acid, Leaflet, Lactic, Poly, Sculptra, Poly l lactic acid, Leaflet sculptra, 174 poly l lactic acid

Protecting the Cold Chain - OCPInfo.com

P!GE 34 ~ SPRING 2012 ~ PH!RM!CY CONNECTION transportation of temperature-sensitive drugs in Canada. 1 Health Canada has also provided guidelines

  Chain, Temperatures, Cold, Sensitive, Of temperature, The cold chain

Page: 1 SAFETY DATA SHEET Revision Date: 06/17/2011 ...

It is possible to breathe this material under certain conditions of handling and use (for example, during heating, spraying, or stirring). Breathing small amounts of this material during normal handling is

  Date, Sheet, Data, Safety, Handling, Revisions, 1 safety data sheet revision date

[Product Monograph Template - Schedule D]

TRESIBA® (insulin degludec injection) Product Monograph Page 4 of 64 . CONTRAINDICATIONS . TRESIBA® (insulin degludec injection) is contraindicated: • In patients who are hypersensitive to TRESIBA® (insulin degludec injection) or to any ingredient …

Preanalytic Laboratory Errors: Identifi cation and Prevention

MayoMedicalLaboratories.com/communique Volume 33 No. 1 5% of all cases, the error resulted in unnecessary investigation or inappropriate patient care.

  Laboratory

MATERIAL SAFETY DATA SHEET - SEDGEHAMMER

Product Name: Sedgehammer Page 2 of 4 Revision Date: 6/27/2011 4. First Aid Measures FIRST AID IF IN EYES Hold eye open and rinse slowly and gently with water for 15-20 minutes. Remove contact lenses, if present, after 5 minutes, then continue rinsing eye. Call poison control center or physician for treatment advice.

  Sheet, Data, Safety, Material, Material safety data sheet

insulin aspart injection 100 units/mL - novo-pi.com

FIASP® (insulin aspart injection) 2 5.7 Fluid Retention and Heart Failure with Concomitant Use of PPAR-Gamma Agonists Thiazolidinediones (TZDs), which are peroxisome proliferator-acti-